Black Friday saleUp to 70% OFF
PPP

PRESCIENT THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

PTX chart


Full chart

PTX upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪29.80 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.010 AUD
Net income (FY)
‪−8.24 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪793.88 M‬
Beta (1Y)
−0.98

About PRESCIENT THERAPEUTICS LIMITED


Sector
Health Technology
Industry
Biotechnology
CEO
Steven Yatomi-Clarke
Website
ptxtherapeutics.com
Headquarters
South Melbourne
Founded
1986
ISIN
AU000000PTX3
FIGI
BBG000J4RZJ3
Prescient Therapeutics Ltd. is a biopharmaceutical company, which engages in the discovery and development of novel immunotherapeutic products for the treatment of chronic infectious diseases and cancer. It develops immune therapeutics based upon its Co-X-Gene and fowlpox virus delivery technologies. The company was founded on May 22, 1986, and is headquartered in South Melbourne, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

PTX news



Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of PTX is 0.037 AUD — it has increased by 2.70% in the past 24 hours. Watch PRESCIENT THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange PRESCIENT THERAPEUTICS LIMITED stocks are traded under the ticker PTX.
PTX stock has fallen by −5.00% compared to the previous week, the month change is a −11.63% fall, over the last year PRESCIENT THERAPEUTICS LIMITED has showed a −51.95% decrease.
PTX reached its all-time high on Jun 28, 2000 with the price of 341.171 AUD, and its all-time low was 0.022 AUD and was reached on Mar 24, 2020. View more price dynamics on PTX chart.
See other stocks reaching their highest and lowest prices.
PTX stock is 2.70% volatile and has beta coefficient of −0.98. Track PRESCIENT THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is PRESCIENT THERAPEUTICS LIMITED there?
Today PRESCIENT THERAPEUTICS LIMITED has the market capitalization of ‪29.80 M‬, it has decreased by −2.56% over the last week.
Yes, you can track PRESCIENT THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
PRESCIENT THERAPEUTICS LIMITED is going to release the next earnings report on Feb 21, 2025. Keep track of upcoming events with our Earnings Calendar.
PTX net income for the last half-year is ‪−4.62 M‬ AUD, while the previous report showed ‪−3.62 M‬ AUD of net income which accounts for −27.61% change. Track more PRESCIENT THERAPEUTICS LIMITED financial stats to get the full picture.
No, PTX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PTX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PRESCIENT THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PRESCIENT THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PRESCIENT THERAPEUTICS LIMITED stock shows the strong sell signal. See more of PRESCIENT THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.